You just read:

Asterias Biotherapeutics Announces Completion of Transfer of AST-VAC2 Manufacturing Process to Cancer Research UK as Milestone Towards Initiating Phase 1/2 Clinical Trial

News provided by

Asterias Biotherapeutics, Inc.

Jan 21, 2016, 07:00 ET